Gwen Melincoff
Directeur/Membre du Conseil chez GAIN THERAPEUTICS, INC.
Fortune : 521 944 $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Michael Heffernan | M | 59 | 22 ans | |
| Anish Bhatnagar | M | 56 | 18 ans | |
| Matthias Alder | M | 59 | 3 ans | |
| Joseph Ciaffoni | M | 53 | 7 ans | |
| Eyal Rubin | M | 48 | 5 ans | |
| Gianluca Fuggetta | M | 35 | 2 ans | |
| Dror Bashan | M | 57 | 5 ans | |
| Ernest Mario | M | 85 | 17 ans | |
| Shirley Kuhlmann | F | 40 | 6 ans | |
| Donald E. Nickelson | M | 91 |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 21 ans |
| David B. Matias | M | - | - | |
| Dov Goldstein | M | 56 | 3 ans | |
| Claude Nicaise | M | 71 | 3 ans | |
| Birgitte Volck | M | 61 | 5 ans | |
| Matthew Pauls | M | 53 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 ans |
| Scott Sudduth | M | - | 6 ans | |
| Shmuel Ben Zvi | M | 64 | 2 ans | |
| Neil McFarlane | M | 51 | 2 ans | |
| Scott Dreyer | M | 52 | 6 ans | |
| Daniel Schneider | M | - | 6 ans | |
| Rita Balice-Gordon | M | 63 | 4 ans | |
| Manolo Bellotto | M | 53 | 6 ans | |
| Andrew Sinclair | M | 52 | 6 ans | |
| Yaron Naos | M | 60 | 20 ans | |
| Eliot Forster | M | 58 | 1 ans | |
| John Freund | M | 70 | 10 ans | |
| Eric Richman | M | 63 | 4 ans | |
| Gino Santini | M | 66 | 12 ans | |
| Claude H. Nash | M | - |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 24 ans |
| Bill Harris | M | 65 | 10 ans | |
| Johanna Holldack | M | - | 7 ans | |
| Hans-Peter Hasler | M | 68 | 3 ans | |
| Jeffrey Riley | M | 61 | 5 ans | |
| Pol Boudes | M | 67 | 5 ans | |
| Khalid Islam | M | 67 | 7 ans | |
| John Fallon | M | 76 | 8 ans | |
| Chaime Orlev | M | 53 | 7 ans | |
| Garen Bohlin | M | 76 | 9 ans | |
| Aharon Schwartz | M | 80 | 10 ans | |
| Amos Bar Shalev | M | 71 | 16 ans | |
| Maja Bergmann | F | - | 5 ans | |
| Christopher James | M | - | 1 ans | |
| Elena Cubero-Jorda | F | - | - | |
| Marissa Samuels | F | - | 2 ans | |
| Fellous Yael | F | - | 2 ans | |
| Colleen Tupper | F | 48 | 3 ans | |
| Charles Horn | M | - | 2 ans | |
| Arun Padmanabhan | M | - | 7 ans | |
| Meredith S. Manning | F | - | - | |
| Lauren Budesheim | F | - | - | |
| Patricia Hirano | F | 58 | 7 ans | |
| Neil M. Cowen | M | - | 7 ans | |
| James Mackaness | M | 60 | 5 ans | |
| Kristen Yen | F | 55 | 18 ans | |
| Geoffrey Coy | M | - | 5 ans | |
| Bart J. Dunn | M | 65 | 5 ans | |
| David P. Geoghegan | M | - |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 20 ans |
| Thomas Smith | M | 63 | 2 ans | |
| Gina Balderas | F | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Michael Dougherty | M | 66 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 11 ans |
| Bruce Peacock | M | 72 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 3 ans |
| Ambrose Bailey | M | 60 | - | |
| Zeev Bronfeld | M | 71 | 17 ans | |
| Matthew Gantz | M | 59 | 7 ans | |
| Kjetil Hestdal | M | 64 | 21 ans | |
| Yoseph Shaaltiel | M | 71 | 27 ans | |
| Michael Metzger | M | 53 | - | |
| Saadia Ozeri | M | 54 | 13 ans | |
| Samuel Rubinstein | M | 59 | 2 ans | |
| Raul Chertkoff | M | - | - | |
| Anders Tuv | M | 46 | - | |
| William Taylor | M | - | 7 ans | |
| Robert Harrell | M | - |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 ans |
| Jonathan R. Wolter | M | 73 | 2 ans | |
| Ruth Wolfson | M | 77 | 14 ans | |
| Alison B. Fleming | M | 49 | 19 ans | |
| Howard Mayer | M | 62 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 6 ans |
| Anne Hovi Worsøe | F | 60 | - | |
| Synne Hermansen Røine | F | 45 | 6 ans | |
| Jan Hendrik Egberts | M | 65 | 6 ans | |
| Michael DeGeorge | M | - | 7 ans | |
| Paul Brannelly | M | 51 | 6 ans | |
| Gil Efron | M | 57 | 6 ans | |
| George V. Hager | M | 68 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | - |
| William Burns | M | 76 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 ans |
| Jeffrey Cooper | M | 68 | 1 ans | |
| Andrew Fromkin | M | 58 | 1 ans | |
| Avri Havron | M | 76 | 8 ans | |
| Stuart J. M. Collinson | M | 64 | 3 ans | |
| Eckard Weber | M | 73 | 1 ans | |
| Patrick Heron | M | 53 | 1 ans | |
| Ian Clements | M | 55 | 1 ans | |
| Dennis Podlesak | M | 66 | 1 ans | |
| Laurent Fischer | M | 60 | 1 ans | |
| Theodore Schroeder | M | 69 | 5 ans | |
| Tom Edward Pike | M | 64 | 6 ans | |
| Pierre Legault | M | 63 | 2 ans | |
| Itzhak Krinsky | M | 71 | 2 ans | |
| Mahendra Shah | M | 79 | 1 ans | |
| Asaf Yosef Frumerman | M | 39 | 2 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 70 | 70,00% |
| Norvège | 10 | 10,00% |
| Israël | 8 | 8,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Gwen Melincoff
- Réseau Personnel
